Displaying 37 - 48 of 102
Metabolism, Alcohol & Toxicity
Introduction

Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity
Targeting obesity as a metabolic treatment approach in NAFLD/NASH

Targeting obesity as a metabolic treatment approach in NAFLD/NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Treatment strategies for improvement of NAFLD/NASH

Treatment strategies for improvement of NAFLD/NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Live discussion

Live discussion

Webcasts
View
Metabolism, Alcohol & Toxicity
The contribution of metabolic co-morbidities and hepatic thyroid hormone dysregulation to the pathophysiology of NASH

The contribution of metabolic co-morbidities and hepatic thyroid hormone dysregulation to the pathophysiology of NASH

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Unmet needs in PBC: the patient perspective

Unmet needs in PBC: the patient perspective

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Welcome & objectives

Welcome & objectives

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Key considerations in the management of cirrhosis in PBC

Key considerations in the management of cirrhosis in PBC

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Q&A

Q&A

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Does our increasing knowledge of PBC pathogenesis affect early management?

Does our increasing knowledge of PBC pathogenesis affect early management?

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Enhancing clinical care strategies in PBC

Enhancing clinical care strategies in PBC

Webcasts
View
Viral Hepatitis
Overview of HBV antigens and relevance to functional cure

Overview of HBV antigens and relevance to functional cure

Webcasts
View
Displaying 37 - 48 of 102